HEALTHCNBC TOP
Chan Zuckerberg Initiative's Biohub to open new rare disease funding round
Chan Zuckerberg Initiative's Biohub will launch a new funding round for rare diseases and expand its AI-driven drug repurposing collaboration with Every Cure.
Mentioned
Related Signal
Adjacent reporting
- STAT+: Astellas treatment offers new hope to a devastated rare disease community
- ORDI honours rare disease champions at Rare Star Awards 2026
- A.P. to strengthen care for rare disease patients, says Health Minister
- STAT+: Angelini Pharma buys Catalyst Pharmaceuticals and its rare disease drugs for $4.1B
- Personalized CRISPR therapies could soon reach thousands — here’s how
- Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaboration